Cure Pharmaceutical Holding Corp. (CURR) at a glance
Cure Pharmaceutical Holding Corp. (CURR) is a small-cap Technology company. It trades at $3.41, with a -48.7% profit margin and revenue decline of 21.8%. It does not pay a dividend. Vestovix scores it 45/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Growth (21/100). It is a relatively defensive holding with below-market volatility.
- Price
- $3.41
- Market cap
- $312.1M
- P/E ratio
- n/a
- Dividend yield
- None
- Beta
- 0.13
- 52-week range
- $1.31 to $4.73
Value
40
Growth
21
Income
40
Safety
80
Momentum
58
Other Technology stocks
See allNVDA55
NVIDIA Corporation
$218.38-4.79%
0.13% yield
AAPL57
Apple Inc.
$332.27+1.66%
0.36% yield
MSFT54
Microsoft Corp.
$494.89+1.69%
0.91% yield
AVGO52
Broadcom Inc.
$361.74-0.85%
0.67% yield
MU54
Micron Technology, Inc.
$975.45-0.49%
0.05% yield
AMD51
Advanced Micro Devices, Inc.
$515.78-1.68%
ASML50
ASML Holding N.V. New York Registry Shares
$1,701.00-2.17%
0.47% yield
INTC38
Intel Corporation
$102.87-2.65%
0.40% yield